Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)
J. Clin. Oncol 2020 Jul 30;[EPub Ahead of Print], PJ Lugtenburg, P de Nully Brown, B van der Holt, FA D'Amore, HR Koene, E de Jongh, R Fijnheer, JW van Esser, LH Böhmer, JF Pruijt, GE Verhoef, M Hoogendoorn, MY Bilgin, M Nijland, NC van der Burg-de Graauw, M Oosterveld, KG Jie, TS Larsen, MW van der Poel, MB Leijs, MH Silbermann, M van Marwijk Kooy, A Beker, MJ Kersten, JK Doorduijn, LW Tick, RE Brouwer, KH Lam, CN Burggraaff, B de Keizer, AI Arens, D de Jong, OS Hoekstra, JM Zijlstra-BaalbergenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.